Vittore Buzzi Children's Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2008
NCT00720538
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Vittore Buzzi Children's Hospital

Active Ingredients

Drugs in Phase 3 Trials (2)

ketamine (ketalar) (1 trial)

thalidomide (Thalomid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Crohn Disease (Phase 3)

Inflammatory Bowel Diseases (Phase 3)

Intestinal Diseases (Phase 3)

Status Epilepticus (Phase 3)

Ulcer (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2